Table 2.
Open in new tab

Supplemental Screening DBT and US Studies

First author, yearStudy periodPopulationScreening modalityNo. of examinationsNo. of cancers on MGNo of ILCs on MGIncremental no. of cancersIncremental no. of ILCsIncremental CDR for cancer (per 1000 examinations)Incremental CDR for ILC (per 1000 examinations)
Berg 2012482004-2006All risks, dense breastsDM + HHUS74735963254.30.67
Brem 2015332009-2011All risks, dense breastsDM + ABUS15 31882113041.90.26
Tagliafico 2016502012-2015Average risk (personal hx BC excluded), dense breasts, negative DMDBT after negative DM3231--1324.00.62
HHUS after DM3231--2347.11.2
HHUS after DBT3231--1123.40.62
Tagliafico 2018512015-2017Dense breasts, negative DMDBT after negative DM53001502.80
HHUS after DM53002644.90.75
HHUS after DBT53001442.60.75
Chough 2020562015-2018Average and intermediate risk, dense breastsDBT + ABUS111160201.80
Ha 2023572017-2019Average risk, dense breasts (personal hx BC excluded)DM + HHUS1726120512.80.58
DBT + HHUS86360303.40
Berg 2023492015-2021All risks, dense breastsDBT + HHUS17 5528781961.080.34
First author, yearStudy periodPopulationScreening modalityNo. of examinationsNo. of cancers on MGNo of ILCs on MGIncremental no. of cancersIncremental no. of ILCsIncremental CDR for cancer (per 1000 examinations)Incremental CDR for ILC (per 1000 examinations)
Berg 2012482004-2006All risks, dense breastsDM + HHUS74735963254.30.67
Brem 2015332009-2011All risks, dense breastsDM + ABUS15 31882113041.90.26
Tagliafico 2016502012-2015Average risk (personal hx BC excluded), dense breasts, negative DMDBT after negative DM3231--1324.00.62
HHUS after DM3231--2347.11.2
HHUS after DBT3231--1123.40.62
Tagliafico 2018512015-2017Dense breasts, negative DMDBT after negative DM53001502.80
HHUS after DM53002644.90.75
HHUS after DBT53001442.60.75
Chough 2020562015-2018Average and intermediate risk, dense breastsDBT + ABUS111160201.80
Ha 2023572017-2019Average risk, dense breasts (personal hx BC excluded)DM + HHUS1726120512.80.58
DBT + HHUS86360303.40
Berg 2023492015-2021All risks, dense breastsDBT + HHUS17 5528781961.080.34

Abbreviations: ABUS, automated whole-breast US; BC, breast cancer; CDR, cancer detection rate; DBT, digital breast tomosynthesis; DM, digital mammography; HHUS, hand-held US; hx, history; ILC, invasive lobular carcinoma; MG, mammogram.

Table 2.
Open in new tab

Supplemental Screening DBT and US Studies

First author, yearStudy periodPopulationScreening modalityNo. of examinationsNo. of cancers on MGNo of ILCs on MGIncremental no. of cancersIncremental no. of ILCsIncremental CDR for cancer (per 1000 examinations)Incremental CDR for ILC (per 1000 examinations)
Berg 2012482004-2006All risks, dense breastsDM + HHUS74735963254.30.67
Brem 2015332009-2011All risks, dense breastsDM + ABUS15 31882113041.90.26
Tagliafico 2016502012-2015Average risk (personal hx BC excluded), dense breasts, negative DMDBT after negative DM3231--1324.00.62
HHUS after DM3231--2347.11.2
HHUS after DBT3231--1123.40.62
Tagliafico 2018512015-2017Dense breasts, negative DMDBT after negative DM53001502.80
HHUS after DM53002644.90.75
HHUS after DBT53001442.60.75
Chough 2020562015-2018Average and intermediate risk, dense breastsDBT + ABUS111160201.80
Ha 2023572017-2019Average risk, dense breasts (personal hx BC excluded)DM + HHUS1726120512.80.58
DBT + HHUS86360303.40
Berg 2023492015-2021All risks, dense breastsDBT + HHUS17 5528781961.080.34
First author, yearStudy periodPopulationScreening modalityNo. of examinationsNo. of cancers on MGNo of ILCs on MGIncremental no. of cancersIncremental no. of ILCsIncremental CDR for cancer (per 1000 examinations)Incremental CDR for ILC (per 1000 examinations)
Berg 2012482004-2006All risks, dense breastsDM + HHUS74735963254.30.67
Brem 2015332009-2011All risks, dense breastsDM + ABUS15 31882113041.90.26
Tagliafico 2016502012-2015Average risk (personal hx BC excluded), dense breasts, negative DMDBT after negative DM3231--1324.00.62
HHUS after DM3231--2347.11.2
HHUS after DBT3231--1123.40.62
Tagliafico 2018512015-2017Dense breasts, negative DMDBT after negative DM53001502.80
HHUS after DM53002644.90.75
HHUS after DBT53001442.60.75
Chough 2020562015-2018Average and intermediate risk, dense breastsDBT + ABUS111160201.80
Ha 2023572017-2019Average risk, dense breasts (personal hx BC excluded)DM + HHUS1726120512.80.58
DBT + HHUS86360303.40
Berg 2023492015-2021All risks, dense breastsDBT + HHUS17 5528781961.080.34

Abbreviations: ABUS, automated whole-breast US; BC, breast cancer; CDR, cancer detection rate; DBT, digital breast tomosynthesis; DM, digital mammography; HHUS, hand-held US; hx, history; ILC, invasive lobular carcinoma; MG, mammogram.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close